MedTrace Logo

Identification and Prognostic Value of Key Genes in Hepatocellular Carcinoma

NCT05759858 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-03-08

No results posted yet for this study

Summary

To explore the key genes of human and mouse hepatocellular carcinoma, identify the key genes and prognostic markers, and develop small molecule drugs targeting the key genes to treat hepatocellular carcinoma.

Conditions

Interventions

OTHER

None of intervention

None of the interventions was applied.

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Sheng Yan, Doctor · 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

  • Yang Tian, Doctor · 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

  • Yuancong Jiang, Doctor · 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-14
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05759858 on ClinicalTrials.gov